Download Free Medical Diagnosis and Management of Schizophrenia PowerPoint Presentation

Diagnosis and Management of Schizophrenia PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Neurology, which is titled "Diagnosis and Management of Schizophrenia", to know about the Diagnosis and Management of Schizophrenia.

Tags : Neurology, Diagnosis, Management, Schizophrenia

Published on : Aug 18, 2021 | Views : 2636 | Downloads : 3

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Diagnosis and Management of Schizophrenia Stephen R. Marder, M.D. Professor and Director, Section on Psychosis Semel Institute for Neuroscience at UCLA VA Desert Pacific Mental Illness Research, Education, and Clinical Center
Slide 2-

Diagnosis and Management of Schizophrenia Process for diagnosing schizophrenia Epidemiology Genetics and environment How to access severity Capacity to Work Current and future treatment
Slide 3-

DSM-IV criteria for schizophrenia Characteristic Symptoms Social/occupational dysfunction Duration of 6 months Schizoaffective and mood disorder exclusion Substance/general medical exclusion Relationship to pervasive developmental disorder
Slide 4-

Diagnostic Process for Schizophrenia Physical and lab exams rule out psychotic disorder due to a medical condition and substance-induced psychosis Imaging (CT, MRI, PET) are seldom helpful in diagnosis The diagnosis is commonly made from history and the mental status exam There are currently no reliable biomarkers for diagnosis or severity
Slide 5-

Characteristic Psychotic Symptoms in Schizophrenia Audible thoughts Voices arguing or commenting Thought withdrawal or insertions by outside forces Thought broadcasting Impulses, volitional acts, or feelings imposed by outside forces Delusional perceptions
Slide 6-

Symptom dimensions in schizophrenia Psychotic Hallucinations Suspiciousness Delusions Negative Impoverished speech Lack of motivation Asociality Decreased Affect Neurocognitive – Impairments Memory Attention Motor skills Social cognition Executive skills Disorganized speech
Slide 7-

Epidemiology of Schizophrenia Lifetime prevalence of about 1% No differences related to culture or race Onset in men is usually earlier (15-24) than in women (25-34)
Slide 8-

Global Burden of Disease 2000 (15-Disease-adjusted Life Years (DALYs) Top 10 Causes of DALYS in Adults (15-44 years) DALY=Sum of years of life lost due to premature mortality and years lost due to disability WHO. The World Health Report 2001. Available at http://www.who.int/whr/2001/en/index.html
Slide 9-

Course of Schizophrenia Age (Years) Good Function Psycho- pathology Poor 15 20 30 40 50 60 70 Sheitman BB, Lieberman JA. The natural history and pathophysiology of treatment-resistant schizophrenia. J Psychiatr Res. 1998(May-Aug);32(3-4):143-150
Slide 10-

Severity in Schizophrenia People with schizophrenia have different levels of disability varying from no disability to complete dependence on institutional care The amount and type of disability is related to the symptoms of the individual’s illness and how responsive these symptoms are to treatment
Slide 11-

Severity in Schizophrenia The severity of psychotic symptoms are related to How distracting Do they influence behavior – eg, command hallucinations Do they cause suffering Do they impair social functioning – eg, suspiciousness
Slide 12-

Severity The severity of negative symptoms are related to Social isolation Apathy Lack of expressiveness The severity of cognitive impairments are related to Poor concentration Poor memory Inability to make simple decisions Inability to interpret social signals Slower pace
Slide 13-

Pharmacological Treatment of Acute Schizophrenia Antipsychotic medications are effective for decreasing the severity of psychotic symptoms Nearly all patients on antipsychotic medications will experience some burden from side effects Antipsychotics are relatively ineffective for negative symptoms and cognitive impairment
Slide 14-

Long-term treatment of schizophrenia Antipsychotic medications are effective for preventing relapse in stabilized patients Effective nonpharmacological treatments include patient and family education, skills training, supported employment, cognitive behavior therapies, and psychotherapies For most individuals, antipsychotic medications control the symptoms while non-pharmacological treatments address the impairments in social, vocational, and educational functioning
Slide 15-

Clinical Challenges Substance use disorders are common in people with schizophrenia Insight can be impaired leading people with schizophrenia to refuse treatment Adherence to treatments can be irregular